R R Ruffolo

3.3k total citations · 2 hit papers
44 papers, 2.8k citations indexed

About

R R Ruffolo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, R R Ruffolo has authored 44 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Biochemistry. Recurrent topics in R R Ruffolo's work include Receptor Mechanisms and Signaling (13 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and Nitric Oxide and Endothelin Effects (7 papers). R R Ruffolo is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and Nitric Oxide and Endothelin Effects (7 papers). R R Ruffolo collaborates with scholars based in United States, United Kingdom and Netherlands. R R Ruffolo's co-authors include J. Paul Hieble, Dan Bylund, Robert J. Lefkowitz, Salomón Z. Langer, Kenneth P. Minneman, Perry B. Molinoff, U. Trendelenburg, G. Feuerstein, David E. Clarke and K P Minneman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and Pharmacological Reviews.

In The Last Decade

R R Ruffolo

43 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology nomenclature of adrenoceptors.

1994 1.0k citations Dan Bylund, J. Paul Hieble et al. Pharmacological Reviews profile →
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

1995 637 citations J. Paul Hieble, Dan Bylund et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R R Ruffolo United States	20	1.5k	906	746	666	359	44	2.8k
Michael T. Piascik United States	22	1.8k 1.2×	1.1k 1.2×	335 0.4×	628 0.9×	200 0.6×	48	2.5k
D P Westfall United States	29	1.6k 1.0×	1.2k 1.3×	579 0.8×	1.2k 1.9×	145 0.4×	59	3.5k
Ikunobu Muramatsu Japan	35	2.4k 1.6×	1.5k 1.7×	407 0.5×	1.2k 1.8×	589 1.6×	243	4.3k
Norio Taira Japan	34	2.0k 1.3×	969 1.1×	1.8k 2.4×	1.1k 1.6×	110 0.3×	250	4.3k
J. Paul Hieble United States	32	2.9k 1.9×	2.0k 2.2×	473 0.6×	1.1k 1.7×	561 1.6×	112	5.1k
Garland A. Johnson United States	14	456 0.3×	328 0.4×	767 1.0×	420 0.6×	308 0.9×	20	2.4k
Koki Shigenobu Japan	31	2.2k 1.5×	974 1.1×	1.9k 2.5×	525 0.8×	91 0.3×	236	3.5k
G. Haeusler Austria	34	1.5k 1.0×	955 1.1×	755 1.0×	821 1.2×	468 1.3×	123	3.5k
Hikaru Suzuki Japan	33	2.1k 1.4×	965 1.1×	920 1.2×	1.8k 2.8×	247 0.7×	166	4.4k
Thomas J. Rimele United States	20	920 0.6×	641 0.7×	167 0.2×	776 1.2×	154 0.4×	47	1.8k

Countries citing papers authored by R R Ruffolo

Since Specialization

Citations

This map shows the geographic impact of R R Ruffolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R R Ruffolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R R Ruffolo more than expected).

Fields of papers citing papers by R R Ruffolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R R Ruffolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R R Ruffolo. The network helps show where R R Ruffolo may publish in the future.

Co-authorship network of co-authors of R R Ruffolo

This figure shows the co-authorship network connecting the top 25 collaborators of R R Ruffolo. A scholar is included among the top collaborators of R R Ruffolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R R Ruffolo. R R Ruffolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruffolo, R R & J. Paul Hieble. (1999). Adrenoceptor Pharmacology: Urogenital Applications. European Urology. 36(Suppl. 1). 17–22. 28 indexed citations

Ohlstein, Eliot H., G. Feuerstein, Anne M. Romanic, & R R Ruffolo. (1998). Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial. Journal of the American College of Cardiology. 31. 469–469.

Ruffolo, R R, et al.. (1997). β-Blocker in Congestive Heart Failure: The Pharmacology of Caronvedilol, a Vasodilating β-Blocker and Antioxidant, and Its Therapeutic Utility in Congestive Heart Failure. Advances in pharmacology. 42. 611–615. 9 indexed citations

Ruffolo, R R & G. Feuerstein. (1997). Pharmacology of Carvedilol: Rationale for Use in Hypertension, Coronary Artery Disease, and Congestive Heart Failure. Cardiovascular Drugs and Therapy. 11(S1). 247–256. 97 indexed citations

Bril, Antoine, Bernard Gout, Laurent Landais, et al.. (1996). Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 637–646. 99 indexed citations

Hieble, J. Paul, Dan Bylund, David E. Clarke, et al.. (1995). International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.. Pharmacological Reviews. 47(2). 267–270. 637 indexed citations breakdown →

Lopez, Bernard L., Theodore A. Christopher, Tianli Yue, et al.. (1995). Carvedilol, a New Beta-Adrenoreceptor Blocker Antihypertensive Drug, Protects against Free-Radical-Induced Endothelial Dysfunction. Pharmacology. 51(3). 165–173. 54 indexed citations

Brooks, David P., M. Gellai, P Nambi, et al.. (1994). Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 769–775. 37 indexed citations

Ohlstein, Eliot H., George R. Beck, P Nambi, et al.. (1994). Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 762–768. 38 indexed citations

10.

Bylund, Dan, J. Paul Hieble, Salomón Z. Langer, et al.. (1994). International Union of Pharmacology nomenclature of adrenoceptors.. Pharmacological Reviews. 46(2). 121–136. 1011 indexed citations breakdown →

11.

Nambi, P, Nabil A. Elshourbagy, M Pullen, et al.. (1994). Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 755–761. 27 indexed citations

12.

Feuerstein, G., Tianli Yue, Cheng Huan, & R R Ruffolo. (1993). Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.. PubMed. 11(4). S41–8. 66 indexed citations

13.

Koster, Paul F., et al.. (1992). Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 269–274. 15 indexed citations

14.

Ruffolo, R R, J. Paul Hieble, David P. Brooks, G. Feuerstein, & Andrew J. Nichols. (1991). Drug receptors and control of the cardiovascular system: Recent advances. Birkhäuser Basel eBooks. 36. 117–360. 10 indexed citations

15.

Brooks, David P., et al.. (1991). Effect of the Dopamine β-Hydroxylase Inhibitor, SK&F 102698, on Blood Pressure in the 1-Kidney, 1-Clip Hypertensive Dog. Pharmacology. 43(2). 90–95. 3 indexed citations

16.

Brooks, David P., David J. Drutz, & R R Ruffolo. (1990). Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 375–379. 19 indexed citations

17.

Kopia, Gregory A., et al.. (1988). Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 956–962. 9 indexed citations

18.

Lin, T. M., et al.. (1986). Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 400–405. 11 indexed citations

19.

Timmermans, P B, et al.. (1984). A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 228(3). 739–748. 44 indexed citations

20.

Ruffolo, R R, E L Yaden, P.B.M.W.M. Timmermans, P. A. van Zwieten, & Martin D. Hynes. (1984). Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 58–66. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact